Manufacturer record
Zaneka Healthcare Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Zaneka Healthcare Ltd (Uttarakhand) were declared Not of Standard Quality between February 2023 and October 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ZCN3G04, Rabeprazole Sodium (EC) and Domperidone (SR) Capsules (Rabihal DSR Capsule) (exp Jun 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Dissolution of Rabeprazole Sodium (Buffer Stage). Listed in the October 2023 alert.
Records by type
2 records linked to Zaneka Healthcare Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Sodium (EC) and Domperidone (SR) Capsules (Rabihal DSR Capsule) | Batch ZCN3G04Mfg Jul 2023 · Exp Jun 2025 | Dissolution of Rabeprazole Sodium (Buffer Stage)Dissolution | CDL KolkataCDSCO lab | Oct 2023 |
| PARACIN - SR (Paracetamol Sustained Release Tablets 1000 mg) | Batch ZTN2I04Mfg Sep 2022 · Exp Aug 2024 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Feb 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.